PCCs are blood products containing clotting factors II, VII, IX, and X, which are essential for the coagulation process. They are derived from human plasma and are used to correct deficiencies in these clotting factors, especially in patients who are experiencing anticoagulation-related bleeding or are at risk of bleeding due to over-anticoagulation.
